Longeveron Revenue

In the year 2025, Longeveron had annual revenue of $1.20M, down -49.87%. Longeveron had revenue of $365.00K in the quarter ending December 31, 2025, a decrease of -39.47%.

Revenue (ttm)

$1.20M

Revenue Growth

-49.87%

P/S Ratio

21.59

Revenue / Employee

$31,553

Employees

Market Cap

25.47M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.20M	-1.19M	-49.87%
Dec 31, 2024	2.39M	1.68M	237.38%
Dec 31, 2023	709.00K	-513.00K	-41.98%
Dec 31, 2022	1.22M	-84.00K	-6.43%
Dec 31, 2021	1.31M	-4.32M	-76.80%
Dec 31, 2020	5.63M	-10.47K	-0.19%
Dec 31, 2019	5.64M	3.50M	164.17%
Dec 31, 2018	2.13M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

LGVN News

21 days ago - Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs) - GlobeNewsWire
6 weeks ago - Longeveron Earnings Call Transcript: Q4 2025 - Transcripts
6 weeks ago - Longeveron Announces 2025 Full Year Financial Results and Provides Business Update - GlobeNewsWire
6 weeks ago - Longeveron Braces For Q4 Results Following Recent Funding Boost - Benzinga
6 weeks ago - Longeveron Announces Closing of Private Placement of up to $30 Million - GlobeNewsWire
7 weeks ago - Longeveron (LGVN) Shares Surge On $30 Million Private Placement Deal - Benzinga
2 months ago - Longeveron® Results of Phase 2b Clinical Trial Demonstrating Stem Cell Therapy Improved Condition of Patients with Age-Related Frailty Published in Cell Stem Cell - GlobeNewsWire
2 months ago - Longeveron® Appoints Stephen H. Willard as Chief Executive Officer - GlobeNewsWire

More News